MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-DL-01-0000887
B.Jain Pharmaceuticals Private Limited - e-commerce in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹50.6 Cr
▲ 43% YoY
Net profit · FY 2024
₹88.01 Lakh
Net margin 1.7%
EBITDA · FY 2024
₹4.46 Cr
EBITDA margin 8.8%
Authorised capital
₹2.5 Cr
Registered with MCA
Paid-up capital
₹2.01 Cr
Issued & subscribed
Open charges
₹25 Cr
Satisfied ₹5 Cr
Company age
20 yrs
Est. 2006
Directors on board
2
As per MCA filings
About B.Jain Pharmaceuticals Private Limited
Data last updated:
B.Jain Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the online healthcare product retail segment of the e-commerce sector. It was incorporated on 23 February 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24231DL2006PTC146748. Its GSTIN is 07AACCB8057F1ZQ (Delhi). The company holds 8 GST registrations, of which 7 are active.
The company has an authorised share capital of ₹2.5 Cr and a paid-up capital of ₹2.01 Cr. It is led by directors Kuldeep Jain and Nishant Jain.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at T – 23 Cross River Mall, Plot No. 9B & 9C CBD, New Delhi, Delhi, India – 110032.
As per the financials filed for FY 2024, the company reported a revenue of ₹50.6 Cr, a growth of 43% compared to the previous year. For the same year it recorded a net profit of ₹88.01 Lakh (net margin 1.7%) and EBITDA of ₹4.46 Cr (EBITDA margin 8.8%). Revenue has grown at a compounded annual rate (CAGR) of 28% over three years and 24% over five years.
The company is associated with 2 brands: Omeo and BJain. As per MCA filings, the company has open charges of ₹25 Cr and satisfied charges of ₹5 Cr on record. Court records list 100 cases involving the company, including 94 filed by the company and 6 filed against it; 21 cases are pending. The company has 6 deals on record (4 funding rounds, 2 secondary share transfers), with disclosed funding of ₹6.68 Cr; the latest was in March 2019. Its 3 peer companies in the Healthcare industry (Alternative Medicine, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 2 larger and 1 smaller; the largest is K. A. Malle Pharmaceuticals Limited with revenue of ₹51.47 Cr. The company has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 26 overdue payments to 26 micro and small suppliers.
B.Jain Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-01-0000887). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website bjainpharma.com.
Company details
CIN U24231DL2006PTC146748
Registration Number 146748
Incorporation Date 23 February 2006
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-DL-01-0000887
Key People
Kuldeep Jain Director Nishant Jain Director Recognitions & Rankings of B.Jain Pharmaceuticals
Contact details
B.Jain Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its website is bjainpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressT – 23 Cross River Mall, Plot No. 9B & 9C CBD, New Delhi, Delhi, India – 110032
- IndustryE-Commerce, Online Healthcare Product Retail
To see the full contact details of B.Jain Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
B.Jain Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
B.Jain Pharmaceuticals operates two associated brands: Omeo and BJain. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Online platform selling natural beauty and personal care products in India. | omeocare.com | |
| Homeopathic medicine manufacturing and online sales in India. | bjainpharma.com |
Business activity
The main business activity of B.Jain Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of B.Jain Pharmaceuticals Private Limited, buy the company report.
Financials of B.Jain Pharmaceuticals Private Limited
FY 2025 filings availableB.Jain Pharmaceuticals Private Limited reported revenue of ₹50.6 Cr (up 43% YoY) for FY 2024.
Revenue · FY 2024
₹50.6 Cr ▲ 43%
Net profit · FY 2024
₹88.01 Lakh margin 1.7%
EBITDA · FY 2024
₹4.46 Cr margin 8.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 43%
3 years · compounded
▲ 28%
5 years · compounded
▲ 24%
EBITDA CAGR growth
1 year
▼ 3%
3 years · compounded
▲ 8%
5 years · compounded
▲ 34%
Revenue has grown at a compounded annual rate (CAGR) of 24% over five years, including 43% growth in the latest year. EBITDA fell 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹50.6 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.46 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹88.01 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.8% | ||||
| Net Profit Margin | 1.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of B.Jain Pharmaceuticals Private Limited, buy the company report.
Board of directors of B.Jain Pharmaceuticals Private Limited
B.Jain Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kuldeep Jain Also directs: B Jain Pegasus LLP, V.K.Buildtech International Private Limited, B.Jain Exports (I) Private Limited and 3 more | Director | 23 Feb 2006 | 20 Years 8 Months | Current |
| Nishant Jain | Director | 26 Jul 2006 | 20 Years 3 Months | Current |
Peer comparison
B.Jain Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Healthcare industry (Alternative Medicine, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| K. A. Malle Pharmaceuticals Limited | ₹51.47 Cr (FY 2025) | 3.0% | Mumbai, Maharashtra, India | |||
| Lord S Homoepathic Laboratory Private Limited | ₹50.7 Cr (FY 2025) | 0.0% | New Delhi, Delhi, India | |||
| B.Jain Pharmaceuticals Private Limitedthis company | ₹50.6 Cr (FY 2024) | ₹88.01 Lakh | 1.7% | 43.0% | New Delhi, Delhi, India | |
| GGC Chemicals & Pharmaceuticals Private Limited | ₹50.18 Cr (FY 2025) | 202.0% | Savli, Gujarat, India |
To see the full peer comparison of B.Jain Pharmaceuticals Private Limited, buy the company report.
Auditor
B.Jain Pharmaceuticals Private Limited is audited by SURAJ GARG AND ASSOCIATES for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SURAJ GARG AND ASSOCIATES | FY 2024 | 008688N |
Shareholding
The shareholding of B.Jain Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of B.Jain Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹25 Cr
Satisfied charges
₹5 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 21 Feb 2025 | 101060107 | Others | ₹33.1 Lakh | Open | |
| 31 Mar 2024 | 100922413 | Hdfc Bank Limited | ₹20 Lakh | Open | |
| 09 Dec 2022 | 100702631 | Hdfc Bank Limited | ₹20 Lakh | Open | |
| 13 Oct 2022 | 100679834 | Hdfc Bank Limited | ₹8.7 Lakh | Open | |
| 30 Jun 2022 | 100597473 | Hdfc Bank Limited | ₹1.18 Cr | Open |
To see the full charge records of B.Jain Pharmaceuticals Private Limited, buy the company report.
Total charge records: 8 View all charges
Deals & funding
B.Jain Pharmaceuticals Private Limited has 6 deals on record (4 funding rounds, 2 secondary share transfers), with disclosed funding of ₹6.68 Cr; the latest was in March 2019.
Total deals
6
Funding rounds
4
Secondary share transfers
2
Disclosed funding
₹6.68 Cr
Deals on record (5 of 6)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2019 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 2 individuals |
| Jul 2017 | Funding round | ₹46.2 Lakh | Investors: B.Jain Exports (I) Private Limited |
| Mar 2012 | Funding round | ₹5.23 Cr | Investors: B.Jain Exports (I) Private Limited , 3 individuals |
| Mar 2009 | Funding round | ₹67 Lakh | Investors: 2 individuals |
| Mar 2009 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
To see the full deal history of B.Jain Pharmaceuticals Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
B.Jain Pharmaceuticals Private Limited has 100 court cases on record: 94 filed by B.Jain Pharmaceuticals, 6 filed against it. 21 cases are pending and 79 are disposed.
Total cases
100
Filed by the company
94
Filed against the company
6
Pending
21
Disposed
79
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 97 | 6 | 20 |
| High courts | 2 | 0 | 0 |
| Supreme Court | 1 | 0 | 1 |
Cases on record (5 of 100)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, South East, Delhi | Civil suit | Filed by the company against SNNR Private Limited | Pending |
| District court, Central, Delhi | Cheque dishonour complaint | Filed by the company against Ayushee Medtonic Pharmacy Private Limited and 1 other | Disposed |
| District court, Gautam Buddha Nagar, Uttar Pradesh | Criminal case | Filed against the company by State of U.P. | Pending |
| District court, Central, Delhi | Cheque dishonour complaint | Filed by the company against an individual | Pending |
| District court, Central, Delhi | Cheque dishonour complaint | Filed by the company against an individual | Pending |
To see the full case history of B.Jain Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
B.Jain Pharmaceuticals Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 26 overdue payments to 26 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 26)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Arjun Bees Wax Industries | |||
| Real Plastochem Private Limited | |||
| an individual supplier | |||
| Om Shree Packaging Private Limited | |||
| Yasham Speciality Ingredients Private Limited |
To see the full MSME payment records of B.Jain Pharmaceuticals Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
B.Jain Pharmaceuticals has 8 GST registrations: 7 active and 1 cancelled or inactive. The first 4 active GSTINs are listed below.
Total GSTINs
8
Active
7
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AACCB8057F1ZQ | Delhi | Active | 01 Jul 2017 |
| 08AACCB8057F1ZO | Rajasthan | Active | 01 Jul 2017 |
| 09AACCB8057F1ZM | Uttar Pradesh | Active | 01 Jul 2017 |
| 29AACCB8057F1ZK | Karnataka | Active | 08 Sep 2022 |
To see the full GST registrations and return filing status of B.Jain Pharmaceuticals Private Limited, buy the company report.
Recent activity
B.Jain Pharmaceuticals Private Limited has 4 board changes on record since 2006: 2 appointments and 2 cessations. The latest: Nitin Jain ceased to be Additional Director on 27 Sep 2014.
Charges
A charge with Hdfc Bank Limited of Rs. 23.00 Cr registered on 23 Sep 2021 with Charge ID 100508689 was modified on 10 Nov 2025.
AGM
B.Jain Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
B.Jain Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
A charge with Others amounted to Rs. 0.33 Cr with Charge ID 101060107 was registered on 21 Feb 2025.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.20 Cr with Charge ID 100922413 was registered on 31 Mar 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.20 Cr with Charge ID 100702631 was registered on 09 Dec 2022.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.09 Cr with Charge ID 100679834 was registered on 13 Oct 2022.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 1.18 Cr with Charge ID 100597473 was registered on 30 Jun 2022.
Charges
A charge registered on 01 Jan 2009 via Charge ID 10142944 with Allahabad Bank was fully satisfied on 07 Dec 2021.
Charges
A charge registered on 01 Jan 2009 via Charge ID 10143592 with Allahabad Bank was fully satisfied on 12 Nov 2021.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 23.00 Cr with Charge ID 100508689 was registered on 23 Sep 2021.
Ceased
Nitin Jain ceased to be Additional Director.
6 earlier events are in the company report.
Frequently asked questions
B.Jain Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in online healthcare product retail, within the e-commerce industry. It was incorporated on 23 February 2006 (20+ years old) and is registered under CIN U24231DL2006PTC146748.
B.Jain Pharmaceuticals has 2 current directors:
- Kuldeep Jain - Director
- Nishant Jain - Director
The latest financial statements of B.Jain Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of B.Jain Pharmaceuticals is 07AACCB8057F1ZQ, registered in Delhi. The company has 8 GST registrations in all, of which 7 are active and 1 is cancelled or inactive. Other active GSTINs include 08AACCB8057F1ZO (Rajasthan), 09AACCB8057F1ZM (Uttar Pradesh), 29AACCB8057F1ZK (Karnataka).
The CIN (Corporate Identification Number) of B.Jain Pharmaceuticals is U24231DL2006PTC146748. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
B.Jain Pharmaceuticals has 100 court cases on record: 94 filed by the company and 6 filed against it. 21 are pending. Most are in the district courts.
B.Jain Pharmaceuticals was incorporated on 23 February 2006, making it 20+ years old. It is registered with the Registrar of Companies, Delhi.
B.Jain Pharmaceuticals has 6 deals on record (4 funding rounds, 2 secondary share transfers), with disclosed funding of ₹6.68 Cr; the latest was in March 2019.
The peers of B.Jain Pharmaceuticals by revenue are K. A. Malle Pharmaceuticals Limited, Lord S Homoepathic Laboratory Private Limited, GGC Chemicals & Pharmaceuticals Private Limited, all in the Healthcare industry (Alternative Medicine, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Nitin Jain ceased to be Additional Director on 27 Sep 2014. Sarwan Jain ceased to be Director on 31 Aug 2012. Nishant Jain was appointed as Director on 26 Jul 2006. B.Jain Pharmaceuticals has 4 board changes on record in total.
Yes, B.Jain Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-DL-01-0000887).
B.Jain Pharmaceuticals has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 26 overdue payments to 26 micro and small suppliers. The latest return was filed on 29 May 2019.